Stock listing
870980 Stock Price, News, Filings & Events — Repligen Corporation
Selected listing: 870980 · LS · EUR · DE
This page tracks Repligen Corporation's 870980:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 870980:LS. 870980:LS is the stock-level entry point for investors researching Repligen Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Repligen Corporation (Ticker: RGEN) is a public company based in America, specializing in bioprocessing technologies for the global life sciences industry. With a market capitalization of approximately $7.44 billion, Repligen focuses on providing innovative solutions that enhance the efficiency and effectiveness of biopharmaceutical manufacturing. The company's offerings support the production of biologics, including monoclonal antibodies...
- Ticker
- 870980:LS
- Asset type
- Stock
- Market cap
- $9.95B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Repligen Corporation 870980:LS stock context
This page tracks Repligen Corporation's 870980:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 870980:LS. 870980:LS is the stock-level entry point for investors researching Repligen Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Repligen Corporation (Ticker: RGEN) is a public company based in America, specializing in bioprocessing technologies for the global life sciences industry. With a market capitalization of approximately $7.44 billion, Repligen focuses on providing innovative solutions that enhance the efficiency and effectiveness of biopharmaceutical manufacturing. The company's offerings support the production of biologics, including monoclonal antibodies...
Latest news from Repligen Corporation
Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference
August 26, 2026
Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance
July 28, 2026
Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media
July 22, 2026
Repligen to Report Second Quarter 2026 Financial Results
July 15, 2026
Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference
May 22, 2026
Repligen Corporation earnings calls
Repligen Corporation (RGEN) Q2 2026 Earnings Call
July 28, 2026 · Replay with transcript and chapters
Repligen Corporation (RGEN) Q1 2026 Earnings Call
May 5, 2026 · Replay with transcript and chapters
Repligen Corporation (RGEN) Q4 2025 Earnings Call
February 24, 2026 · Replay with transcript and chapters
Repligen Corporation (RGEN) Q3 2025 Earnings Call
October 28, 2025 · Replay with transcript and chapters
Repligen Corporation (RGEN) Q2 2025 Earnings Call
July 29, 2025 · Replay with transcript and chapters
Repligen Corporation (RGEN) Q1 2025 Earnings Call
April 29, 2025 · Replay with transcript and chapters
Research Repligen Corporation
Repligen Corporation investor report
Review AI stock analysis and investor report context for 870980:LS.
Repligen Corporation company profile
View the public company page for Repligen Corporation on 6ix.
Repligen Corporation news
Read company news and market updates connected to Repligen Corporation.
Repligen Corporation investor events
Find investor webinars, events, and replay context for Repligen Corporation.
Alternate listings
RGEN:NASDAQ
US · USD
Alternate listing for Repligen Corporation; the primary context on this page is 870980:LS.
RGN:GETTEX
DE · EUR
Alternate listing for Repligen Corporation; the primary context on this page is 870980:LS.
RGN:TRADEGATE
DE · EUR
Alternate listing for Repligen Corporation; the primary context on this page is 870980:LS.
870980:LSX
DE · EUR
Alternate listing for Repligen Corporation; the primary context on this page is 870980:LS.
R2GE34:BMFBOVESPA
BR · BRL
Alternate listing for Repligen Corporation; the primary context on this page is 870980:LS.
RGN:FWB
DE · EUR
Alternate listing for Repligen Corporation; the primary context on this page is 870980:LS.
1RGEN:MIL
IT · EUR
Alternate listing for Repligen Corporation; the primary context on this page is 870980:LS.
RGEN:BOATS
US · USD
Alternate listing for Repligen Corporation; the primary context on this page is 870980:LS.
RGN:BX
CH · CHF
Alternate listing for Repligen Corporation; the primary context on this page is 870980:LS.
RGN:DUS
DE · EUR
Alternate listing for Repligen Corporation; the primary context on this page is 870980:LS.
RGN:MUN
DE · EUR
Alternate listing for Repligen Corporation; the primary context on this page is 870980:LS.
RGN:SWB
DE · EUR
Alternate listing for Repligen Corporation; the primary context on this page is 870980:LS.